EMCDDA Home
  • EN
Search

Table TDI-10. Primary drug and age. EU, Croatia, Norway and Turkey, 2011 or most recent year available

Part (v) Age distribution, New inpatient clients (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opioids0.05.519.425.021.613.98.36.331.230120
Cocaine0.55.417.623.521.413.59.58.732.06540
Stimulants0.318.730.224.615.66.52.41.726.312151
Hypnotics and sedatives0.23.713.012.612.310.09.838.440.54301
Hallucinogens0.025.623.327.916.34.72.30.025.4430
Volatile substances7.454.515.710.78.31.71.70.021.01210
Cannabis 1.524.529.019.711.76.93.03.725.917201
Other substances 0.919.228.220.712.06.22.310.528.55321
Total0.613.523.322.417.010.15.87.129.477274
 

Notes

The number of treatment clients in each country is listed in Table TDI-7.

See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012 — Table TDI outpatient and inpatient treatment centres.

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013